Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

FB 04 - Universitätsmedizin

Johannes Gutenberg-Universität Mainz

Obere Zahlbacher Str. 63, Geb. 912, 55131 Mainz
  • 06131/17-9704 oder 9799 (Sekretariat)
  • 06131/17-9669
Publikationen
Ergebnisse pro Seite:  10

Lammich, S; Buell, D; Zilow, S et al.

Expression of the Anti-amyloidogenic Secretase ADAM10 Is Suppressed by Its 5 '-Untranslated Region

JOURNAL OF BIOLOGICAL CHEMISTRY. Bd. 285. H. 21. 2010 S. 15753-15760


Cheng, F; Torzewski, M; Degreif, A et al.

EXPRESSION OF VARIOUS ISOFORMS OF GLUTATHIONE PEROXIDASE IN THE AORTA OF GPX-1 (/) ApoE (/) MICE DURING ATHEROSCLEROTIC LESION DEVELOPMENT

ATHEROSCLEROSIS SUPPLEMENTS. Bd. 11. H. 2. 2010 S. 99-99


Knackstedt, LA; Moussawi, K; Lalumiere, R et al.

Extinction Training after Cocaine Self-Administration Induces Glutamatergic Plasticity to Inhibit Cocaine Seeking

JOURNAL OF NEUROSCIENCE. Bd. 30. H. 23. 2010 S. 7984-7992



Pliushch, G; Schneider, E; Weise, D et al.

Extreme Methylation Values of Imprinted Genes in Human Abortions and Stillbirths

AMERICAN JOURNAL OF PATHOLOGY. Bd. 176. H. 3. 2010 S. 1084-1090


Debus, F; Herth, MM; Piel, M et al.

F-18-Labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging

NUCLEAR MEDICINE AND BIOLOGY. Bd. 37. H. 4. 2010 S. 487-495


Luckey, UM; Lorenz, N; Grabbe, S et al.

F4/80+antigen presenting cells are not critical for induction of tolerance but for control of contact hypersensitivity

EXPERIMENTAL DERMATOLOGY. Bd. 19. H. 2. 2010 S. 167-167


Popov, Y; Sverdlov, DY; Sharma, A et al.

F4/80+CD11B-SUBSET OF RESIDENT MACROPHAGES CRITICALLY DETERMINES MOUSE STRAIN DIFFERENCES IN SUSCEPTIBILITY TO LIVER FIBROSIS

HEPATOLOGY. Bd. 52. H. 4. 2010 S. 1289A-1290A


Mehta, A; Beck, M; Eyskens, F et al.

Fabry disease: a review of current management strategies

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE. Bd. 103. H. 9. 2010 S. 641-659


Merz, C; Mengel, E; Hartung, R et al.

Fabry disease: change-over of preparations may avoid infusion-related adverse events and secure continuation of enzyme replacement therapy

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. Bd. 48. 2010 S. S63-S64